Oncology PracticeOmega-3 supplements may impact breast cancer riskDecember 13, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeWomen struggle with benzodiazepine addiction post chemotherapy treatmentDecember 13, 2021Metastatic Breast CancerBreast Cancer
Oncology Practice‘Surprising’ lack of benefit to adding palbociclib to endocrine therapy in early HR+/HER2– breast cancerDecember 13, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeGenomic instability varies between breast cancer subtypesDecember 10, 2021Metastatic Breast Cancer
Oncology PracticeOngoing HER2 breast cancer therapy may cost an additional $68,000 per patientDecember 10, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeVitamin D counters bone density loss with aromatase inhibitorsDecember 10, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeMetformin does not improve outcomes in early breast cancerDecember 10, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeGenomic profiling can improve PFS in metastatic breast cancerDecember 8, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeCDK4/6 inhibitors: Should they be stopped in the face of COVID-19?December 8, 2021Metastatic Breast Cancer
Oncology PracticeNovel SERD reduces risk of death by 30% in HR+ breast cancerDecember 8, 2021Metastatic Breast Cancer
Oncology PracticeBlack women most at risk for lymphedema after ALNDDecember 8, 2021Metastatic Breast Cancer
Oncology PracticeIn metastatic breast cancer, primary resections on the declineDecember 8, 2021Metastatic Breast Cancer
Oncology PracticeWhat’s hot at the world’s premiere breast cancer meetingDecember 1, 2021Metastatic Breast Cancer
Oncology PracticeRisk for breast cancer recurrence persists past 30 yearsNovember 18, 2021Metastatic Breast CancerBreast Cancer
